Remo Inglin
Chief Financial Officer
Training
- Master of Science in Business and Economics (lic. rer. pol.), University of Basel
Professional career
- 1991-2004 worked in various financial functions at Novartis Valeant Pharmaceuticals and HIAG
- 2004-2016 Group Controller Corporate, CFO Novartis Pharma Basel and Novartis Pharma Switzerland
- 2016-2020 Country CFO, Novartis Germany (2019-2020 CPO Head/GM ad interim Germany)
- 2020-2021 Lead ESG Reporting, Novartis Group
- 2021-2023 Group CFO, Advanced Acceleration Applications (AAA), Geneva
- until 07.2023 Head Accounting Switzerland, Implenia Schweiz AG (Interim Manager)
- since 14.08.2023 CFO at the University Hospital Zurich
Secondary occupations and mandates
